CORT has been in the news 313% more than usual
Mar 06, 2026, 1:32 AM
0.00%
What does CORT do
Corcept Therapeutics, based in Menlo Park, California, is a commercial-stage pharmaceutical company that markets Korlym for Cushing's syndrome and has a portfolio of selective cortisol modulators. Founded in 2004, it employs 352 people and offers around 1,000 compounds.
CORT has been in the news recently: Corcept Therapeutics is facing multiple class action lawsuits from investors alleging securities fraud and misleading claims related to its product candidate, relacorilant, during the period from October 31, 2024, to December 30, 2025. Following these allegations, the company's stock price significantly dropped by 50% after claims surfaced that it disregarded FDA warnings regarding its drug submission.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.